Ad Header



The Pulse of the Pharmaceutical Industry

  • Filter By Category

  • Filter By Author

Lymphoma Drug Flunks Phase III Test

Gazyva combined with chemotherapy failed to meet its primary endpoints in a Phase III trial for patients with previously untreated diffuse large B-cell lymphoma.

Read More »

AstraZeneca PLC Announces MedImmune Layoffs, But Does Not Specify Numbers or Location

According to Derek Lowe, writing in his “In The Pipeline” blog for Science Translational Medicine on July 15, AstraZeneca has announced job cuts at its MedImmune division. The gist of the rumors was confirmed by a Friday, July 15 statement released by the company.

Read More »

China approves GSK’s Cervarix for cervical cancer

The China Food and Drug Administration has approved GSK’s human papillomavirus vaccine Cervarix for use in the country to help women fight cervical cancer.

Read More »

AstraZeneca’s lung cancer drug meets main goal in late-stage trial

AstraZeneca Plc said its experimental lung cancer drug Tagrisso met its main goal in a late-stage study.

Read More »

Samsung Bioepis seeks Europe approval for its Humira copy

Biosimilars maker Samsung Bioepis, part of South Korea’s top family-run conglomerate Samsung Group, said it is seeking regulatory approval in Europe to sell its copy of AbbVie Inc.’s rheumatoid arthritis drug Humira.

Read More »

Herbalife settles pyramid scheme case with regulator, in blow to Pershing’s Ackman

Herbalife Ltd. agreed to a $200 million settlement with U.S. regulators under which the dietary supplements maker will change the way it does business and avoid being labeled a pyramid scheme, a blow to hedge fund manager Bill Ackman who for years has been betting against the company.

Read More »

Valeant psoriasis drug’s suicide risk hard to assess

Valeant’s experimental drug to treat psoriasis carries a potential risk of suicide that is challenging to assess due to limited data, according to an FDA preliminary review.

Read More »

Pharma Bro Martin Shkreli Gets Trial Date, Couldn’t Wait to Play Pokémon Go After Hearing

Martin Shkreli will finally have his day in court. The disgraced former pharmaceutical entrepreneur will face a judge in June 2017, Reuters reported.

Read More »

Juno Stock Falls Again After Correcting Number of Trial Deaths

Juno Therapeutics has indicated that instead of three patient fatalities out of 129 cases for the company’s Phase II clinical trial of JCAR015 for relapsed or refractory B cell acute lymphoblastic leukemia, there were actually four.

Read More »

Ziopharm Reports Clinical Trial Death

Boston’s Ziopharm Oncology released information that a patient receiving gene therapy into a brain tumor died from an intracranial hemorrhage.

Read More »

Ad Right Top


Extensive pharmaceutical business and marketing intelligence. For back issues, please contact

December 2018 Focus: Healthcare Agency Roundtable, Mobile Marketing, and more!


Ad Right Bottom